Bruno Raphael Romano, Wernly Bernhard, Binneboessel Stephan, Baldia Philipp, Duse Dragos Andrei, Erkens Ralf, Kelm Malte, Mamandipoor Behrooz, Osmani Venet, Jung Christian
Medical Faculty, Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria.
Diagnostics (Basel). 2020 Dec 18;10(12):1105. doi: 10.3390/diagnostics10121105.
Early lactate clearance is an important parameter for prognosis assessment and therapy control in sepsis. Patients with a lactate clearance >0% might differ from patients with an inferior clearance in terms of intensive care management and outcomes. This study analyzes a large collective with regards to baseline risk distribution and outcomes.
In total, 3299 patients were included in this analysis, consisting of 1528 (46%) ≤0% and 1771 (54%) >0% patients. The primary endpoint was intensive care unit (ICU) mortality. Multilevel logistic regression analyses were used to compare both groups: A baseline model (model 1) with lactate clearance as a fixed effect and ICU as a random effect was installed. For model 2, patient characteristics (model 2) were included. For model 3, intensive care treatment (mechanical ventilation and vasopressors) was added to the model. Models 1 and 2 were used to evaluate the primary and secondary outcomes, respectively. Model 3 was only used to evaluate the primary outcomes. Adjusted odds ratios (aORs) with respective 95% confidence intervals (CI) were calculated.
The cohorts had no relevant differences regarding the gender, BMI, age, heart rate, body temperature, and baseline lactate. Neither the primary infection focuses nor the ethnic background differed between both groups. In both groups, the most common infection sites were of pulmonary origin, the urinary tract, and the gastrointestinal tract. Patients with lactate clearance >0% evidenced lower sepsis-related organ failure assessment (SOFA) scores (7 ± 6 versus 9 ± 6; < 0.001) and creatinine (1.53 ± 1.49 versus 1.80 ± 1.67; < 0.001). The ICU mortality differed significantly (14% versus 32%), and remained this way after multivariable adjustment for patient characteristics and intensive care treatment (aOR 0.43 95% CI 0.36-0.53; < 0.001). In the additional sensitivity analysis, the lack of lactate clearance was associated with a worse prognosis in each subgroup.
In this large collective of septic patients, the 6 h lactate clearance is an independent method for outcome prediction.
早期乳酸清除率是脓毒症预后评估和治疗控制的重要参数。乳酸清除率>0%的患者在重症监护管理和预后方面可能与清除率较低的患者有所不同。本研究分析了一个大型队列的基线风险分布和预后情况。
本分析共纳入3299例患者,其中1528例(46%)乳酸清除率≤0%,1771例(54%)乳酸清除率>0%。主要终点是重症监护病房(ICU)死亡率。采用多水平逻辑回归分析对两组进行比较:建立一个以乳酸清除率为固定效应、ICU为随机效应的基线模型(模型1)。模型2纳入了患者特征。模型3在模型中加入了重症监护治疗(机械通气和血管活性药物)。模型1和模型2分别用于评估主要和次要结局。模型3仅用于评估主要结局。计算调整后的比值比(aOR)及相应的95%置信区间(CI)。
两组在性别、体重指数、年龄、心率、体温和基线乳酸水平方面无显著差异。两组的主要感染部位和种族背景均无差异。两组中最常见的感染部位均为肺部、泌尿系统和胃肠道。乳酸清除率>0%的患者脓毒症相关器官功能衰竭评估(SOFA)评分较低(7±6 vs 9±6;<0.001),肌酐水平也较低(1.53±1.49 vs 1.80±1.67;<0.001)。ICU死亡率有显著差异(14% vs 32%),在对患者特征和重症监护治疗进行多变量调整后仍保持这一差异(aOR 0.43,95%CI 0.36 - 0.53;<0.001)。在额外的敏感性分析中,乳酸清除率缺乏与各亚组中较差的预后相关。
在这个大型脓毒症患者队列中,6小时乳酸清除率是一种独立的预后预测方法。